USA Rare Earth secured a major government collaboration, boosting its stock and funding. Production and financial targets for 2030 have been upgraded, but risks remain. The agreement was announced in ...

Otter triplets are extremely rare, and raising them pushes a mother to her limits. Otter triplets are extremely rare, and raising them pushes a mother to her limits. When the smallest cub ventures out ...

Otter triplets are extremely rare, and raising them pushes a mother to her limits. When the smallest cub ventures out on his own in search of food, he strays too far and becomes separated from his ...

Retired General Jack Keane has joined REalloys’ board, signaling that rare-earth metallization is now being treated as a core national security priority, not just an industrial issue. The ...

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...

LONDON, Feb 11 (Reuters) - CME Group (CME.O), opens new tab is working on a plan to launch the world's first futures contract in rare earths, three sources with knowledge of the matter told Reuters, ...

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...

MP Materials operates the only rare-earth metals mine in the U.S., but USA Rare Earth aims to change that. Both mining companies are positioning themselves to benefit from future demand for permanent ...

When a 50-year-old Swedish mom decided she wanted just one more baby, she pictured a single newborn slotting into an already busy household. Instead, she found herself preparing for three at once and ...

EXCLUSIVE: Industry experts warn the United States is "one crisis away" from losing access to the rare earth elements that power everything from fighter jets to electric vehicles — a vulnerability ...

Researchers identify genetic mutation in small group of people who developed the serious disorder after receiving the AstraZeneca or Johnson & Johnson vaccine. About one in 200,000 people developed ...